MedPath

Utidelone

Generic Name
Utidelone
Drug Type
Small Molecule

Overview

Utidelone (UTD1), a novel microtubule stabilizing agent, is an epothilone B analogue produced by genetic engineering. It is under investigation in clinical trials for various cancers.

Background

Utidelone (UTD1), a novel microtubule stabilizing agent, is an epothilone B analogue produced by genetic engineering. It is under investigation in clinical trials for various cancers.

Indication

联合卡培他滨,用于既往接受过至少一种化疗方案的复发或转移性乳腺癌患者。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/02/24
Phase 2
Not yet recruiting
2025/01/09
Phase 2
Recruiting
2024/12/12
Phase 2
Not yet recruiting
2024/11/11
Phase 2
Not yet recruiting
2024/09/19
Phase 2
Recruiting
2024/07/19
Phase 2
Not yet recruiting
2024/06/13
Phase 2
Recruiting
Min Yan, MD
2024/04/26
Phase 2
Recruiting
2023/11/09
Phase 2
Recruiting
Huihua Xiong
2023/10/26
Phase 2
Recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Utidelone Injection
国药准字H20210011
化学药品
注射剂
3/11/2021
Utidelone Injection
国药准字H20247320
化学药品
注射剂
12/18/2024

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath